Cargando…
Quest for Quality in Translational Stroke Research—A New Dawn for Neuroprotection?
Despite tremendous progress in modern-day stroke therapy, ischemic stroke remains a disease associated with a high socioeconomic burden in industrialized countries. In light of demographic change, these health care costs are expected to increase even further. The current causal therapeutic treatment...
Autores principales: | Haupt, Matteo, Gerner, Stefan T., Bähr, Mathias, Doeppner, Thorsten R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140731/ https://www.ncbi.nlm.nih.gov/pubmed/35628192 http://dx.doi.org/10.3390/ijms23105381 |
Ejemplares similares
-
Neuroprotective Strategies for Ischemic Stroke—Future Perspectives
por: Haupt, Matteo, et al.
Publicado: (2023) -
Lithium beyond psychiatric indications: the reincarnation of a new old drug
por: Haupt, Matteo, et al.
Publicado: (2021) -
Preconditioning Concepts for the Therapeutic Use of Extracellular Vesicles Against Stroke
por: Haupt, Matteo, et al.
Publicado: (2023) -
Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke
por: Doeppner, Thorsten R., et al.
Publicado: (2017) -
Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke
por: Hermann, Dirk M., et al.
Publicado: (2022)